Lv4
660 积分 2022-11-04 加入
Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA)
20天前
已完结
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
20天前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
4个月前
已完结
Artificial Intelligence Across the Obesity Continuum: From Mechanistic Insights to Global Precision Prevention and Therapy
4个月前
已完结
Mapping the effectiveness and risks of GLP-1 receptor agonists
4个月前
已完结
Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade
4个月前
已完结
Targeting activin E: insights in to role in adipose tissue and prospects for weight loss therapeutic development
4个月前
已完结
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease
5个月前
已完结
Balancing weight and muscle loss in GLP1 receptor agonist therapy
5个月前
已完结
Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease
6个月前
已完结
皖公网安备34019202002308
